| Basics |
| Company: |
Harvard Bioscience, Inc. |
| IPO Date: |
April 1, 2001 |
| Sector: |
Healthcare |
| Industry: |
Life Sciences Tools and Services |
| Market Cap: |
$43M |
| Activated in VL: |
True |
| Average Daily Range |
| Avg Daily Range: |
$0.10 | 2.44%
|
| Avg Daily Range (30 D): |
$0.06 | 3.76%
|
| Avg Daily Range (90 D): |
$0.07 | 3.38%
|
| Institutional Daily Volume |
| Avg Daily Volume: |
.1M |
| Avg Daily Volume (30 D): |
.24M |
| Avg Daily Volume (90 D): |
.17M |
| Trade Size |
| Avg Trade Size (Sh.): |
171 |
| Avg Trade Size (Sh.) (30 D): |
173 |
| Avg Trade Size (Sh.) (90 D): |
134 |
| Institutional Trades |
| Total Inst.Trades: |
157 |
| Avg Inst. Trade: |
$1.68M |
| Avg Inst. Trade (30 D): |
$1.39M |
| Avg Inst. Trade (90 D): |
$1.39M |
| Avg Inst. Trade Volume: |
.41M |
| Avg Inst. Trades (Per Day): |
1 |
| Market Closing Trades |
| Avg Closing Trade: |
$6.09M |
| Avg Closing Trade (30 D): |
$.96M |
| Avg Closing Trade (90 D): |
$.96M |
| Avg Closing Volume: |
1.46M |
|
|
|
|
| News |
Jan 24, 2025 @ 9:58 AM
Microelectrode Array In Vitro Market to Reach US$ ...
Source: The Insight Partners
|
Jan 13, 2025 @ 10:52 PM
Harvard Bioscience, Inc. to Participate in the ...
Source: N/A
|
Oct 29, 2024 @ 9:00 PM
Harvard Bioscience Schedules Third Quarter 2024 Ea...
Source: N/A
|
Jun 6, 2024 @ 8:05 PM
Harvard Bioscience, Inc. to Present and Host One-o...
Source: Harvard Bioscience, Inc.
|
May 23, 2024 @ 8:05 PM
Harvard Bioscience, Inc. to Present at the Jeff...
Source: Harvard Bioscience, Inc.
|
| Financials |
| |
TTM |
Q3 2024 |
Q2 2024 |
|
Basic EPS
|
$-.33
|
$-.11
|
$-.07
|
|
Diluted EPS
|
$-.33
|
$-.11
|
$-.07
|
|
Revenue
|
$ 97.73M
|
$ 21.97M
|
$ 23.1M
|
|
Gross Profit
|
$ 57.08M
|
$ 12.77M
|
$ 13.22M
|
|
Net Income / Loss
|
$ -14.24M
|
$ -4.8M
|
$ -2.93M
|
|
Operating Income / Loss
|
$ -5.94M
|
$ -1.87M
|
$ -2.07M
|
|
Cost of Revenue
|
$ 40.65M
|
$ 9.21M
|
$ 9.88M
|
|
Net Cash Flow
|
$ -.81M
|
$ .15M
|
$ -.21M
|
|
PE Ratio
|
|
|
|
|
